Friday, August 11, 2017 8:05:44 PM
The Company & Management continues to demonstrate promising results.
I especially like the fact that they took the time to put together a shareholder update and guidance section in their press release.
Overall;
- Top line results were very impressive with 44%+ growth over last year
- Gross margins increased from Q1-17 (42.7% to 45.7% - more in line with historical norms but still slightly lower than 47% in the same quarter last year)
- SG&A did increase on a dollar amount basis but proportionately to the revenue it actually decreased to 27.2% of revenue vs. 28.7% of revenue in the same quarter last year.(reasonable given they are ramping up so many programs) Depreciation was up by 100k over last year which is a non-cash item anyway (and simply means they added more infrastructure/bought more equipment to help them grow)
- By my own EBITDA calculations (which is how I like to look at things) EBITDA was 634k this Quarter vs. 448k in the same quarter last year (EBITDA margins were 18.5% vs 18.9% last year simply due to slightly lower GM%)
-Overall very good performance, but what I like most is the update/guidance. To obtain between 15-15.5M over the whole year the Company would need to have Q3-Q4 make up between 8.3-8.8M which means the growth in the second half of this year over the same period last year has to be between 42% to 51%. Not to mention the Company must have fairly good certainty on these numbers as we are already partly through Q3 and they have already shown they have grown from the current 139 programs to 160 (15% growth in programs - the same growth that was seen in the current Q's program growth 120-->139). Adding another 60+ programs by year end would mean an over 44% growth in number of programs within less than 6 months).
- Given the currently available information, my "reasonable Targets for the stock are 1.50$ for 2017FYE and 2.10$+ for 2018FYE.
_____________________________________________________________________
Valuation (including next FY estimates)
Current Fiscal Year Revenue: (46.5% growth) ~15.25M in 2017 (mid-point of guidance) / 2018FY estimate:21.3M (assume 40% growth)
Gross margins: 46% ~7.015M for 2017 / 9.8M for 2018
SG&A as a % of revenue 26% ~ 3.96M for 2017 / 5.5M for 2018
D&A and other: ~900k (First Half*2) / 1.2M for 2018
EBITDA:3.05M for 2017 / 4.3M for 2018
NI:2.15M for 2017 / 3.1M for 2018
F.d. share Count: 44.1M
Assumed cash balance in 12 months:~2M$ for 2017 (1.4M currently plus a conservative additive cash flow of 300k/Q)
Assumed LT debt:0$
**all multiples come from S&P capitalIQ from companies in a similar industry.
All methods use Median multiples to be more conservative.
Method 1 - EV/Sales:
Mean EV/Sales Multiple:4.3x
15.25M*4.3=EV of 65.5MM add back cash less debt=equity value of 67.7M/44M shares gives a share value of 1.53$/share
Method 2 - EV/EBITDA:
Mean EV/EBITDA Multiple:15.3x
3.05M*15.3=EV of 46.6M add back cash less debt=48.7M/44M= 1.10$ per share
Method 3 - EV/Earnings (or P/E):
Believe it or not the average P/E in this sector is 40.5x - I'll be using the median of 33.9x.
NI of 2.15M*x33.9=72.88M EV add cash = 74.8M/44M shares= 1.70$/share
Based on the above calculations a 1.50$/share target is within reach if the company trades towards its fair value and hits its guidance. Using the same metrics 2.10$ or more would not be out of reach in the following fiscal year. (and if they got bought out - I could easily see someone taking them out between 3-5$/share)
Best of luck!
E.
Recent PAYS News
- Paysign to Host First Quarter 2024 Earnings Call • Business Wire • 04/09/2024 08:30:00 PM
- Paysign, Inc. to Sponsor the 2024 International Plasma Protein Congress April 16-17 • Business Wire • 03/14/2024 08:30:00 PM
- Paysign, Inc. Reinforces Payment Processing Acumen With New Executive Hire • Business Wire • 03/13/2024 08:30:00 PM
- Paysign, Inc. to Sponsor the 2024 Gene Therapy for Rare Disorders Conference March 26-29 • Business Wire • 03/12/2024 08:30:00 PM
- Paysign Inc. to Sponsor the 2024 ACCESS USA Conference March 19-21 • Business Wire • 03/11/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 11:22:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 11:14:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 01:07:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 12:51:22 PM
- Paysign to Host Fourth Quarter and Full Year 2023 Earnings Call • Business Wire • 02/27/2024 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:01:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 10:55:56 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 05:36:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 11:50:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 11:44:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 11:57:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 11:49:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 12:50:43 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 12:26:53 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 12:03:20 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/24/2024 09:05:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 12:56:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 09:00:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/02/2023 09:44:16 PM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM